AAM Slams Medicare Delays For First Generics
US Association Urges Federal And State Policymakers To Act
The AAM has cited multiple reasons for the failure of Medicare Part D to get new generics to its patients, forcing up their costs. The association has offered a list of suggestions to “ensure that first generics are covered at launch, with lower cost-sharing.”
